Kings Path Partners LLC
- SEC CIK
- 0002030974
- Latest filing
- Jul 14, 2026
LGND holding history
Ligand Pharmaceuticals Inc in every 13F filed by Kings Path Partners LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
LGND overviewAll 13F holders of LGNDFull Q2 2026 holdings
- Shares (Q2 2026)
- 3,960
- Value
- $1.25M
- % of portfolio
- 0.3%
- Quarters held
- 9
- Since Q2 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 3,960 | $1.25M | 0.3% | 00.0% | Unchanged | Holders |
| Q1 2026 | 3,960 | $790.6K | 0.3% | 00.0% | Unchanged | Holders |
| Q4 2025 | 3,960 | $748.7K | 0.3% | 00.0% | Unchanged | Holders |
| Q3 2025 | 3,960 | $701.5K | 0.3% | −1,105−21.8% | Reduced | Holders |
| Q2 2025 | 5,065 | $575.8K | 0.2% | 00.0% | Unchanged | Holders |
| Q1 2025 | 5,065 | $532.5K | 0.3% | −3,195−38.7% | Reduced | Holders |
| Q4 2024 | 8,260 | $885.1K | 0.4% | 00.0% | Unchanged | Holders |
| Q3 2024 | 8,260 | $826.7K | 0.3% | +1,380+20.1% | Added | Holders |
| Q2 2024 | 6,880 | $579.7K | 0.3% | – | No prior filing | Holders |